Related references
Note: Only part of the references are listed.Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target
Alfredo Perales-Puchalt et al.
CLINICAL CANCER RESEARCH (2017)
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
T. L. Mao et al.
GENE THERAPY (2017)
Controlling Directed Protein Interaction Networks in Cancer
Krishna Kanhaiya et al.
SCIENTIFIC REPORTS (2017)
Mucinous ovarian cancer: A therapeutic review
Wen Xu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities
J. Alejandro Rauh-Hain et al.
GYNECOLOGIC ONCOLOGY (2016)
Precision targeted therapy of ovarian cancer
Justin Sapiezynski et al.
JOURNAL OF CONTROLLED RELEASE (2016)
CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection
Salai Madhumathi Parkunan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?
Konstantinos Papadimitriou et al.
MOLECULAR DIAGNOSIS & THERAPY (2016)
Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation
Nicoletta Staropoli et al.
ONCOTARGET (2016)
Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex
Zhi-Yao He et al.
SCIENTIFIC REPORTS (2016)
Mycobacterium tuberculosis-triggered Hippo pathway orchestrates CXCL1/2 expression to modulate host immune responses
Monoranjan Boro et al.
SCIENTIFIC REPORTS (2016)
D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma
Xue Li et al.
BIOCONJUGATE CHEMISTRY (2015)
PEG-PEI/siROCK2 Protects Against Aβ42-Induced Neurotoxicity in Primary Neuron Cells for Alzheimer Disease
Yunyun Liu et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2015)
A simple and high-throughput in-cell Western assay using HepG2 cell line for investigating the potential hypocholesterolemic effects of food components and nutraceutics
Carmen Lammi et al.
FOOD CHEMISTRY (2015)
IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo
Mythili Koneru et al.
ONCOIMMUNOLOGY (2015)
Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA)
Mani Roshan Moniri et al.
CYTOTECHNOLOGY (2015)
Retro-Inverso CendR Peptide-Mediated Polyethyleneimine for Intracranial Glioblastoma-Targeting Gene Therapy
Jing Wang et al.
BIOCONJUGATE CHEMISTRY (2014)
Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy
Lingling Fan et al.
GYNECOLOGIC ONCOLOGY (2014)
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study
Ronald D. Alvarez et al.
GYNECOLOGIC ONCOLOGY (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
In vitro cytotoxicity assessment based on KC50 with real-time cell analyzer (RTCA) assay
Tianhong Pan et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2013)
Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature
De-Hong Yu et al.
BIOMATERIALS (2010)
The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat
Bing Liang et al.
BIOMATERIALS (2009)
Follicle-Stimulating Hormone Peptide Can Facilitate Paclitaxel Nanoparticles to Target Ovarian Carcinoma In vivo
Xiao-yan Zhang et al.
CANCER RESEARCH (2009)
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2009)
In-Cell Western assay: a new approach to visualize tissue factor in human monocytes
EM Egorina et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Partial D-amino acid substitution:: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide
R Tugyi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
RM Schiffelers et al.
NUCLEIC ACIDS RESEARCH (2004)
Share Paper
